InChI=1S/C26H36O5/c1- 18(2) 7- 6- 8- 19(3) 25- 21(17- 27) 12- 15- 23(26(25) 30- 5) 31- 24(28) 16- 11- 20- 9- 13- 22(29- 4) 14- 10- 20/h8- 11,13- 14,16- 18,21,23,25- 26H,6- 7,12,15H2,1- 5H3/b16- 11+,19- 8+/t21- ,23- ,25- ,26- /m1/s1 |
VZXWJOQUYPNRPF-JUVJZELASA-N |
[H]C(=O)[C@H]1CC[C@@H](OC(=O)\C=C\c2ccc(OC)cc2)[C@@H](OC)[C@@H]1\C(C)=C\CCC(C)C |
|
View more via ChEBI Ontology
Outgoing
|
(1R,2S,3S,4S)- 4- formyl- 2- methoxy- 3- [(2E)- 6- methylhept- 2- en- 2- yl]cyclohexyl (2E)- 3- (4- methoxyphenyl)acrylate
(CHEBI:48414)
has functional parent
(1S,2S,3S)-3-methoxy-2-[(2E)-6-methylhept-2-en-2-yl]-4-oxocyclohexanecarbaldehyde
(CHEBI:48411)
(1R,2S,3S,4S)- 4- formyl- 2- methoxy- 3- [(2E)- 6- methylhept- 2- en- 2- yl]cyclohexyl (2E)- 3- (4- methoxyphenyl)acrylate
(CHEBI:48414)
has functional parent
4-methoxycinnamic acid
(CHEBI:48541)
(1R,2S,3S,4S)- 4- formyl- 2- methoxy- 3- [(2E)- 6- methylhept- 2- en- 2- yl]cyclohexyl (2E)- 3- (4- methoxyphenyl)acrylate
(CHEBI:48414)
has functional parent
fumagalone
(CHEBI:48530)
(1R,2S,3S,4S)- 4- formyl- 2- methoxy- 3- [(2E)- 6- methylhept- 2- en- 2- yl]cyclohexyl (2E)- 3- (4- methoxyphenyl)acrylate
(CHEBI:48414)
has role
angiogenesis inhibitor
(CHEBI:48422)
(1R,2S,3S,4S)- 4- formyl- 2- methoxy- 3- [(2E)- 6- methylhept- 2- en- 2- yl]cyclohexyl (2E)- 3- (4- methoxyphenyl)acrylate
(CHEBI:48414)
is a
aldehyde
(CHEBI:17478)
(1R,2S,3S,4S)- 4- formyl- 2- methoxy- 3- [(2E)- 6- methylhept- 2- en- 2- yl]cyclohexyl (2E)- 3- (4- methoxyphenyl)acrylate
(CHEBI:48414)
is a
enoate ester
(CHEBI:51702)
|
|
(1R,2S,3S,4S)- 4- formyl- 2- methoxy- 3- [(2E)- 6- methylhept- 2- en- 2- yl]cyclohexyl (2E)- 3- (4- methoxyphenyl)prop- 2- enoate
|
1(R)- 2(S)- 3(S)- 4(S)- 3- (4- methoxy- phenyl)- acrylic acid 3- (1,5- dimethyl- hex- 1- enyl)- 4- formyl- 2- methoxy- cyclohexyl ester
|
Patent
|
9954516
|
Reaxys Registry Number
|
Reaxys
|
|